BrainGate is the longest-running clinical trial program in intracortical brain-computer interfaces, representing a collaboration among Brown University, Massachusetts General Hospital, Stanford University, and other leading institutions. Since its first human implant in 2004, BrainGate has been responsible for many of the field's most significant milestones, demonstrating that people with severe paralysis can use decoded brain signals to control computers, robotic arms, and communication devices.
The BrainGate system uses Utah Arrays implanted in the motor cortex to record the firing patterns of dozens to hundreds of individual neurons. Machine learning algorithms decode these patterns in real time, translating intended movements into cursor motions, keystrokes, or robotic arm commands. Participants in BrainGate trials have achieved remarkable feats — from typing at competitive speeds to controlling a tablet computer for email and web browsing to drinking from a bottle using a mind-controlled robotic arm.
BrainGate's contributions extend far beyond individual demonstrations. The consortium has generated the largest body of long-term human intracortical data in existence, establishing safety benchmarks and decoding methodologies that inform the entire BCI industry. Companies like Neuralink, Blackrock Neurotech, and Synchron all build on foundational work from BrainGate researchers. As the field transitions from research to commercial products, BrainGate's clinical datasets remain an essential reference for regulatory submissions and device design. For deeper coverage, see BCIIntel.